IHS vs VEON
IHS Holding Ltd. and Veon Ltd., side by side — 7 fiscal years reported in USD, drawn from SEC filings.
Most recent reported year
| Metric | IHS | VEON |
|---|---|---|
| Revenue | $1.6B | $4.4B |
| Net income | $143.6M | $591.0M |
| Gross margin | 55.4% | · |
| Net margin | 8.0% | 13.4% |
| Return on equity | · | · |
| Diluted EPS | $0.42 | $0.30 |
| Dividend / share | · | $0.00 |
| Payout ratio | · | · |
| Free cash flow | $718.7M | · |
| Equity | $-251.3M | $1.3B |
| Net debt / equity | · | 1.05× |
| Current ratio | 2.08× | · |
| Revenue CAGR 5y | 2.4% | 4.8% |
| Profit CAGR 5y | · | · |
VEON bills 2.8× the revenue of IHS, and keeps more of each dollar of revenue as profit (13.4% against 8.0%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner. "·" marks a figure not available in our data.
7 years side by side
| Fiscal year | IHS | VEON |
|---|---|---|
| FY2025 | $1.6B | $4.4B |
| FY2024 | $1.5B | $4.0B |
| FY2023 | $1.9B | $3.7B |
| FY2022 | $2.0B | $3.8B |
| FY2021 | $1.6B | $3.9B |
| FY2020 | $1.4B | $3.5B |
| FY2019 | $1.2B | $8.1B |
Bottom line
| Fiscal year | IHS | VEON |
|---|---|---|
| FY2025 | $143.6M | $591.0M |
| FY2024 | $-1.6B | $487.0M |
| FY2023 | $-2.0B | $-2.5B |
| FY2022 | $-459.0M | $-9.0M |
| FY2021 | $-25.8M | $801.0M |
| FY2020 | $-322.0M | $-316.0M |
| FY2019 | $-423.5M | $683.0M |
7 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | −$2,817,000,000 | VEON |
| FY2024 | −$2,476,800,000 | VEON |
| FY2023 | −$1,772,700,000 | VEON |
| FY2022 | −$1,793,701,000 | VEON |
| FY2021 | −$2,270,270,000 | VEON |
| FY2020 | −$2,078,851,000 | VEON |
| FY2019 | −$6,857,944,000 | VEON |
VEON has reported the higher revenue in every one of these 7 fiscal years. The gap has narrowed since the earliest year compared.
7 of 11 comparable fiscal years — a year missing data on either side is not counted.
7 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | −5.4 pp | VEON |
| FY2024 | −119.8 pp | VEON |
| FY2023 | −37.0 pp | VEON |
| FY2022 | −23.7 pp | VEON |
| FY2021 | −22.5 pp | VEON |
| FY2020 | −13.9 pp | VEON |
| FY2019 | −42.8 pp | VEON |
VEON has kept the higher net margin in every one of these 7 fiscal years.
7 of 11 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
IHS's net margin has been more volatile than VEON's over the 7 comparable fiscal years — 43.0 percentage points of standard deviation against 27.4.
7 of 11 comparable fiscal years — a year missing data on either side is not counted.
Year by year
VEON led in net margin in every one of the 7 comparable fiscal years — a structural lead, not a recent swing.
7 of 11 comparable fiscal years — a year missing data on either side is not counted.